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Provision of exercise services in patients
with peripheral artery disease in the United
Kingdom
Amy E Harwood1, Sean Pymer2, Said Ibeggazene3, Lee Ingle4,
Eddie Caldow5, and Stefan T Birkett6
Abstract
Objectives: Supervised exercise programmes (SEPs) are a vital treatment for people with intermittent claudication,
leading improvements in walking distance and quality of life and are recommended in multiple national and international
guidelines. We aimed to evaluate the use and structure of SEPs in the United Kingdom (UK).
Design: We conducted an anonymous online survey using the Jisc platform comprising of 40 questions. The survey was
designed to address key areas such as access, provision, uptake and delivery of SEPs in the United Kingdom. Ethical approval
was obtained from Coventry University (P108729).
Methods: The list of trusts providing vascular services was obtained from the National Vascular Registry (NVR) report.
The survey was disseminated via social media, The Vascular Society of Great Britain and Ireland and the Society for Vascular
Technology. Data were exported to a Microsoft Excel document and analysed using simple descriptive statistics.
Results:Of 93 vascular units identified, we received response from 48. Of these, 23 had access to an exercise programme (48%).
The majority of SEPs were exclusively for PAD patients (77%), with 21% using integrated services. 67% of respondents were
providing a circuit-based programme, and 5 out of 23 were meeting the dose recommendations in the UK National Institute for
Health and Care Excellence (NICE) guidelines. Respondents felt that programmes were moderately to extremely important to
patients, slightly to very important to clinicians and not at all important to slightly important to commissioning/funding bodies.
Conclusion: SEPs are a well-established first-line treatment for patients with IC and they are recommended by NICE
guidelines. Despite this, many patients still do not have access to an exercise programme, and clinicians do not feel that they
have support from commissioning/funding bodies to develop them. There is an urgent need for funding, development and
delivery of SEPs in the United Kingdom.
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What this paper adds
We have provided a comprehensive overview of the
availability, structure and delivery of supervised exercise
programmes in the United Kingdom. We have also iden-
tified barriers to implementation and characterised how
clinicians feel that programmes are valued by patients and
commissioning bodies. There is an urgent need for funding,
development and delivery of SEPs in the UK.
Introduction
Globally, over 236 million people are estimated to have
peripheral artery disease (PAD).2 A classic symptom of
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PAD is intermittent claudication (IC), which is characterised
by muscle pain or discomfort in the legs brought on by
physical exertion.3 This pain can be severely disabling and
is associated with reduced walking duration, functional
capacity, balance and muscle strength.4-6
Across many national and international clinical guidelines,
the first-line treatment of IC includes secondary prevention of
cardiovascular disease risk factors and a supervised exercise
programme (SEP).7-10 These SEPs generally include a
walking-based programme to moderate or maximal claudi-
cation pain, typically 3 days per week for around 60 min.11
SEPs are efficacious for improving clinical indicators
such as maximum walking distance and quality of life.7,12
However, it is acknowledged that the overall availability of
programmes 13,14 and uptake and adherence15 to programmes
is low. Further, the adherence to guideline recommended
therapy is low16 Indeed, a survey we conducted in 2016
demonstrated that only 39% of vascular units in the United
Kingdom had access to a SEP.13 This lack of availability was
also recently highlighted in the United States, whereby 54% of
respondents did not have access to a programme.17 This in-
formation should have raised awareness of this limited
availability and led to increased SEP provision. For centres
with a SEP, the lack of detail and consistency between
guidelines may impact upon effective implementation.11
We therefore aimed to evaluate the availability, use and
structure of SEPs in the UK National Health Service (NHS)
and update our previous survey from 2016. We wanted to
understand how programmes are being implemented by
whom and where and how respondents thought exercise
programmes are valued by patients, clinicians and
commissioning/funding groups. We also wanted to identify
possible barriers to implementation.
Methods
Study design
We developed an English language anonymous online
survey using the Jisc online survey platform (https://www.
onlinesurveys.ac.uk/). The survey consisted of 40 ques-
tions, although not all questions were presented to all re-
spondents as Boolean operators were used to determine
whether further relevant questions were asked according to
how questions were answered. The survey was designed to
address key areas such as access, provision, uptake and
delivery of SEPs in the United Kingdom. Most questions
were closed, but there was also the option to provide
comments and/or responses to some questions where an
‘other’ option was selected. The full survey outline is
provided in the supplementary material.
Primary ethical approval was obtained from the Research
Ethics Committee at Coventry University (P108729) prior
to the commencement of the survey. Respondents provided
electronic consent via a tick box at the beginning of the
survey and could not access the survey if they did not
consent to participate.
To ensure clarity, appropriateness and functionality, we
developed the survey in conjunction with vascular con-
sultants, nurses, physiotherapists and exercise physiologists
and piloted it prior to disseminating it more widely.
Study respondents
We aimed to obtain responses from all trusts who carry out
vascular clinics and operations for PAD. The list of trusts
providing vascular services was obtained from the National
Vascular Registry (NVR) report,1 with a total of 93 trusts
identified. First, the survey was disseminated via social
media (TwitterTM), The Vascular Society of Great Britain
and Ireland news page and the Society for Vascular
Technology. Emails were then sent to trusts who had not
responded. Respondents to the survey were asked to
identify which trust they worked for and what role they
undertook, but no other personal identifying questions were
asked to maintain anonymity.
Data analysis
Data were exported from the Jisc online survey platform to a
Microsoft Excel document and analysed using simple de-
scriptive statistics. No responses were excluded from the
analysis.
Results
We identified 93 hospital trusts in the United Kingdom with
dedicated vascular units from the most recent NVR database
report. Of these, we received responses from 48 units (52%).
In addition, we had 12 responses from additional healthcare
trusts and one GP practice response. We also had two re-
sponses from the same trust but covering separate hospital/
spoke sites. Therefore, in total, we had 63 respondents. The
survey was completed by a variety of people including
nurses, vascular consultants and registrars, podiatrists, ex-
ercise professionals and physiotherapists. Overall, 48% of
respondents had access to a SEP, 49% did not have access
and 3% did not know. Specifically, 23 vascular units in-
dicated that they had an exercise programme.
Service model
Figure 1 shows the limited access to SEPs across the United
Kingdom and the spread of services. The majority of SEPs
were hospital-based (62%) with community (31%) and
spoke services (7%) also providing programmes. Most were
NHS funded (77%), while 10% did not know how their
programme was funded. Nurses were most often the clinical
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lead for the SEP (42%), followed by physiotherapists (21%),
vascular consultants (17%), exercise professionals (10%)
and a joint nurse and physiotherapist lead (3%). Some
centres (7%) did not know or did not have a clinical lead.
Most SEPs provided some form of formal education (76%),
however, 17% did not, while 7% did not know. Patients were
provided with recommendations for increasing their habitual
physical activity in most programmes (80%). Home-based
exercise booklets and pedometers were the most adopted
methods to use at home. An assessment of patients’ car-
diovascular risk factors prior to entering an exercise pro-
gramme was undertaken by 67% of respondents, with 7%
not undertaking any form of risk factor assessment prior to
entry and the remaining stating that risk factors were as-
sessed by a vascular consultant/registrar prior to referral.
Programme delivery
The majority of SEPs were exclusively for PAD patients
(77%) although some integrated PAD into cardiac rehabil-
itation (14%) and multi-morbidity (9%) programmes. The
sessions were mostly group-based (73%) and predominantly
led by a physiotherapist (36%), followed by an exercise
professional (25%), a nurse (21%) or other (17.9%). Table 1
one provides an overview of the exercise testing and pre-
scription (dose) as reported by respondents. The most
commonly cited patient barrier to a SEP was time, both in
terms of personal time or travel time. Other barriers included
no transport or an inability to access public transport, fi-
nancial limitations and too much pain when walking.
Requirement and perceptions of service provision
The resources used to guide SEPs included national guidance
such as the National Institute for Health and Care Excellence
(NICE), research articles, The Circulation Foundation
website and/or sport and exercise science statements.Word of
mouth and expert opinion were also reported. Clinicians
reported that access to exercise facilities, additional staff with
expertise, equipment and funding would help with the im-
plementation of an exercise programme where one was not
available. If centres did not have a specific exercise pro-
gramme, basic walking advice and smoking cessation was
often provided to patients. Only 30% of programmes offered
a specific home-based exercise prescription which included a
home-based exercise booklet or structured exercise guidance.
Figure 2 demonstrates that most respondents felt that pro-
grammes were moderately to extremely important to patients,
slightly to very important to clinicians and not at all important
to slightly important to commissioning and funding bodies.
Discussion
SEPs are recommended by vascular guidelines and clinical
groups as the first-line treatment for patients with IC.
Particularly within the United Kingdom, NICE has ad-
vocated SEPs since 2012.8 However, this survey highlights
that access to SEPs still remains highly variable across the
United Kingdom with limited change since surveys con-
ducted in 2009 and 2016.13,18 It is important to consider
that some centres that did not respond to this survey may
offer a SEP, meaning that the figure of 48% may be a slight
underestimation. Nevertheless, Figure 1 clearly demon-
strates that there is a lack of service provision across large
areas of the country, indicating that some patient may not
be receiving the optimal treatment. It also demonstrates
that some patients may need to travel a considerable
distance depending on the area covered by each trust;
indeed, travel and financial limitations were reported as
barriers to SEPs in this survey. However, we acknowledge
the possibility of missing data in regions like the North
East.
One interesting finding is that while programmes are
deemed to be extremely important to clinicians and clini-
cians feel that they are valuable for patients, they are
considered less important to commissioning/funding bodies
who are the ones responsible for deciding if a service needs
implementing within the hospital setting. Indeed, funding
(as with the last survey in 2016) was highlighted as a major
barrier to implementation.13 This is despite the recom-
mendations made by NICE. Further investment from
commissioning groups for SEPs is desperately needed and
this requires urgent attention.
Integration into existing service
One way of mitigating the need for new exercise pro-
grammes could be via the integration of patients with IC
into existing infrastructure such as cardiac rehabilitation.19
Indeed, we had three respondents indicating that their PAD
class was run in conjunction with cardiac rehabilitation
with two of these as part of a multi-morbidity rehabilitation
model. The coronary artery disease patient and the PAD
patient have a shared atherosclerotic pathophysiology and
often have similar risk factor profiles and common co-
morbidities (hypertension, diabetes and pulmonary dis-
ease). Cardiac rehabilitation is well developed in the
United Kingdom, with 233 programmes available,20
providing a potential opportunity to integrate services
where they are currently not available. There is limited
evidence for integrated rehabilitation into cardiac services
or community schemes, so it remains to be established
whether outcomes for patients are the same irrespective of
the rehabilitation service.21 If services are integrated,
providers will need to ensure familiarity with various
vascular-specific outcome measures (such as maximum
walking distance) and the requirement to incorporate
exercises that provoke claudication pain, to align with
recommended exercise prescriptions.11
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Clinical guidelines for exercise services
Alongside funding restrictions and availability of facil-
ities, another aspect that may limit SEP development is
the lack of detail provided in the NICE guidelines to
support implementation. The simple description of
‘2 hours of supervised exercise a week for a 3-month
period encouraging people to exercise to the point of
maximal pain’ does not provide enough detail to fully
allow for easy implementation. Indeed, the exercise
prescription differed vastly between centres in our sur-
vey, likely due to this limited guidance. We recently
Figure 1. Overview of access to supervised exercise programmes (tick = access, cross = no access and question mark = don’t know).
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published a more comprehensive summary of exercise
prescriptions to aid clinicians implementing exercise
programmes.11 Outlined components included a clinical
assessment, risk stratification and pre-exercise (baseline)
testing to establish an appropriate exercise dose (in-
tensity and time). This baseline testing should have at
least one method of measuring walking distance (graded
exercise test or six-minute walking distance conforming
to appropriate guidelines).22,23 This measurement should
also be repeated or continuously evaluated to ensure that
the training intensity is sufficient. During the exercise
session, a validated scale such as the claudication pain
scale should be used to ensure that patients are walking
to maximal pain where tolerated.24 Based on the
available literature, the exercise programme should
ideally be provided at least 3 days per week for at least
3 months, up to 60 min per session.7 It is encouraging
that many of the respondent’s programmes followed
these guidelines, although most programmes were still
conducted less than three times per week which may be
suboptimal.25 By providing such detailed guidance, we
may have made implementation easier, while also ad-
dressing some of the knowledge-based concerns that
were highlighted by respondents who did not have an
exercise programme, potentially reducing some provi-
sion barriers.11
Table 1. Overview of programme delivery in supervised exercise programmes.




Yes – 80% (24/30) Baseline tests included ABPI and/or a form
of walking exercise testNo – 10% – (3/30)
Don’t know – 10% (3/30)
Pre-programme
exercise test
Yes – 83% (20/24) Exercise tests included a graded or
constant load treadmill test, the ISWT
or the 6MWT. Strength was measured
in two programmes
No – 17% (4/24)
Methods for
prescription
Claudication pain scale – 50% (13/26) The claudication pain scale (0–4 or 1–5).
No prescription included patients who
‘self-prescribed’ during the exercise
sessions. Mixed relates to the use of
RPE and %HRR in conjunction with the
pain scale
No prescription – 38% (10/26)




12 weeks – 50% (15/30)
<12 weeks – 23% (7/30
>12 weeks – 13.5% (4/30)>12 weeks – 13.5% (4/30)




1x week – 50% (15/30)
2x week – 23% (7/30)
3x week – 4% (1/30)




30 mins–7% (2/30) Average session duration of programmes
was 1226 min over 12 weeks, with 5
out of 23 meeting the NICE
recommendation of 2 h per week for
12 weeks (1440 min)
30–60 mins – 70% (21/30)
>60 mins – 7% (2/30)
Don’t know – 16% (5/30)
Mode of
exercise
Walking only – 13% (4/30) Mixed included walking in conjunction
with a circuit format and/or RT. Only
30% of programmes included a RT
component in the exercise sessions
Mixed – 67% (20/30)




Yes – (66%) (20/30) Exercise tests included a graded or
constant load treadmill test, the ISWT
or the 6MWT.
No – 17% (5/30)
Don’t know - 17% (5/30)
Strength was measured in two
programmes
aABPI = ankle brachial pressure index; ISWT = incremental shuttle walk test; 6MWT = six-minute walk test; RPE = rating of perceived exertion; %HRR =
percentage of heart rate reserve; RT = resistance training.
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Exercise modality
Interestingly, while evidence in the literature indicates that
walking should be the primary mode of exercise, which is
replicated in the national and international guidance11 most
of our respondents who had exercise programmes were
providing a circuit-based programme format. It is possible
that equipment limitations (i.e. treadmills), most likely
make treadmill-based SEPs relatively infeasible in clinical
practice, due to cost and limits on number of people per
session. Furthermore, solely walking-based interventions
may not be the most preferred option for patients, and a
circuit-based format provides the opportunity to incorporate
resistance/strength training exercises, which will not only be
beneficial for muscle strength but also walking distance.26,27
Uptake and adherence
Encouragingly where data were available from sites, ap-
proximately 80–95% of referred patients started the exercise
programme, with around 50% of these completing it. A
number of respondents were unaware of patient attendance
rates, and so these findings provide a limited understanding
of real-world uptake and adherence rates, although we know
that generally uptake and adherence rates are much lower
than this.15 To support SEPs and rehabilitation services for
patients with IC, to record uptake and adherence and to
ensure quality and effectiveness of delivery, a model based
on the ‘National Audit of Cardiac Rehabilitation’ could be
considered to record vital service-level information. Pres-
ently service evaluation for exercise programmes in PAD is
lacking and there is no standardised framework to support it.
Alongside this, the development of standardised pre- and
post-exercise evaluation principles is important to dem-
onstrate improvements in patients and to evaluate different
services and their differing prescriptions. Not all respon-
dents in the survey indicating that their centre were able to
conduct exercise assessments, particularly post-exercise
evaluations.
Alternative modes of provision
While we know that SEPs are the ‘gold-standard’method of
exercise delivery,28 several programmes reported the use of
home-based exercise prescription, in particular the use of an
exercise booklet. While these programmes are not currently
recommended by NICE, they have been important during
the COVID-19 pandemic and have some evidence to
support their use. Various models of home-based exercise
programmes have been evaluated.29,30 However, evidence
is heterogenous largely down to variations in the methods of
delivery, components of the programme and variability in
the exercise dose. A recent systematic review has dem-
onstrated that while home-based programmes are inferior to
Figure 2. Overall respondents’ views on importance of supervised exercise programmes to patients, clinicians and commissioning
groups.
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SEPs, they are certainly better than providing no exercise or
basic exercise advice.30 Furthermore, including a form of
active monitoring such as a pedometer or other device in-
creases the benefit of a home-based programme.30 Moni-
toring also means that patients are provided with regular
feedback and that the exercise prescription can be structured
and personalised. There is, however, a need to further de-
velop and evaluate home-based exercise interventions, par-
ticularly those including smart technology such as app-based
platforms which can provide feedback and opportunities for
remote supervision. It is crucial that patients are part of this
development in a co-production format, so that they are
designed to meet the needs of the end-user. We also need to
understand and trial the delivery of home-based exercise
services to understand what barriers there may be. Ultimately
it may not be a one-size-fits-all approach with a need to have
several different options for patients.
Limitations
Despite our best efforts to obtain a response from every UK
vascular unit registered on the most recent NVR report, we
did not capture all data. However, our response rate is
similar to that of 2016, and we believe that our findings are
representative of all centres. We also anticipated a response
bias in favour of those who had exercise programmes.
However, the largest number of respondents was those that
did not, indicating that this was unlikely.
Conclusion
SEPs are a well-established first-line treatment for patients
with IC and they are recommended by NICE guidelines.
Despite this, many patients still do not have access to an
exercise programme, and clinicians do not feel that they
have support from funding bodies and commissioning
groups to develop them. There is an urgent need for funding,
development and delivery of supervised exercise services
in the United Kingdom. Furthermore, there is a need for
a greater evidence base for home-based exercise services
to aid delivery where a face-to-face service may be
impractical.
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